Notes in Week 2 Pharm

To Subscribe, use this Key

Status	Last Update	Fields
Published	03/11/2025	Phenylephrine MOA:  {{c1::α1 agonist}}
Published	02/20/2025	Phenylephrine therapeutics:{{c1::Hypotension}} due to {{c1::vasodilation}} (shock, anesthesia)Short-term {{c1::vasoconstriction}}{{c1::Decongestant}}
Published	03/11/2025	Phenylephrine adverse effects:{{c1::Hypertension}}{{c1::Bradycardia}}
Published	02/20/2025	Doxazosin MOA: {{c1::α1 antagonist}}
Published	02/20/2025	Doxazosin therapeutics:{{c1::Benign prostatic hyperplasia (BPH)}}{{c1::Pheochromocytoma}}{{c1::Hypertension}} (rare)
Published	02/22/2025	Clonidine MOA: {{c1::α2-AdR agonist}}Inhibits {{c1::sympathetic output}}↓ {{c1::arteriolar resistance (↓ TPR)}}↓ {{c1::venous resistance (↓ EDV)}}↓ {{…
Published	02/20/2025	Clonidine therapeutics:Mild to moderate {{c1::hypertension}}{{c1::Opiate}} withdrawal
Published	02/20/2025	Clonidine adverse effects:{{c1::Postural hypotension}}{{c1::Bradycardia}}{{c1::Sedation}}{{c1::Dry mouth}}{{c1::Impotence}}{{c1::Rebound hypertension}…
Published	02/20/2025	Atropine MOA: pan {{c1::muscarinic}} receptor {{c1::antagonist}} ({{c1::pan antimuscarinic}})
Published	02/20/2025	Atropine therapeutics: {{c1::AChE inhibitory}} toxicity {{c1::Vagal bradycardia}} reversal
Published	02/20/2025	What is the adverse effect of atropine? {{c1::Tachycardia}}
Published	02/22/2025	Phentolamine MOA: {{c1::α1/2-AdR antagonist}}
Published	02/20/2025	Phentolamine therapeutics:Extravastion of {{c1::adrenergic agonists}}Severe {{c1::hypertension}} due to increased {{c1::catecholamine}} activity
Published	02/20/2025	Phentolamine adverse effects:{{c1::Orthostatic hypotension}}{{c1::Tachycardia}}{{c1::Nasal congestion}}
Published	02/20/2025	Dobutamine MOA: {{c1::β1 agonist}}
Published	02/20/2025	Pyridostigmine is an {{c1::AChE inhibitor}} → {{c1::decreases::decreases/increases}} ACh degredation → {{c1::increases::decreases/increases}} ACh
Published	02/20/2025	Dobutamine therapeutics:Acute {{c1::heart failure (cardiogenic shock)}}{{c1::Cardiac stress}} testing
Published	02/20/2025	Pyridostigmine therapeutics: {{c1::Myasthenia gravis}}{{c1::Neurogenic orthostatic}} hypotension
Published	02/20/2025	Dobutamine adverse effects:{{c1::Tachycardia}}
Published	02/20/2025	What are the adverse effects of pyridostigmine? {{c1::Respiratory}} depression {{c1::Bradycardia}} {{c1::Lacrimation}} {{c1::Diarr…
Published	02/20/2025	Metoprolol MOA: {{c1::β1 antagonist}}
Published	02/20/2025	Metoprolol therapeutics:{{c1::Systolic heart failure}}{{c1::Hypertension}}{{c1::Angina}}
Published	02/20/2025	Metoprolol adverse effects:{{c1::Bradycardia}}{{c1::AV}} block{{c1::Fatigue}}{{c1::Bronchoconstriction}}
Published	02/20/2025	Isoproterenol MOA: {{c1::β1/2 agonist}}
Published	02/20/2025	Isoproterenol therapeutics:{{c1::Bradycardia}} (limited use)
Published	02/20/2025	Isoproterenol adverse effects:{{c1::Tachycardia}}{{c1::Hypotension}}
Published	02/20/2025	Propranolol MOA: {{c1::β1/2 antagonist}}
Published	02/24/2025	Propranolol therapeutics:{{c1::Angina}}{{c1::Arrhythmias}}Essential {{c1::tremor}}{{c1::Performance}} anxiety{{c1::Migraine}}
Published	02/20/2025	Propranolol adverse effects:{{c1::Bradycardia}}{{c1::Bronchoconstriction}}
Published	02/22/2025	Epinephrine MOA: {{c1::β1/2}} > {{c1::α1/2 agonist}}
Published	02/20/2025	Epinephrine therapeutics:{{c1::Cardiac arrest}}{{c1::Anaphylaxis}}
Published	02/20/2025	Epinephrine adverse effects:{{c1::Tachycardia}}{{c1::Extravasation necrosis}}
Published	02/22/2025	Norepinephrine MOA: {{c1::α1/2}} > {{c1::β1}} > {{c1::β2 agonist}}
Published	02/20/2025	Norepinephrine therapeutics:Acute {{c1::hypotensive}} states such as {{c1::septic shock}}
Published	03/08/2025	Carvedilol is a {{c1::α1/β1/2 antagonist }}Decreased {{c2::arteriolar}} ({{c2::TPR}}) resistance at {{c1::α1}} receptor → vaso{{c2::dil…
Published	02/20/2025	Norepinephrine adverse effects:{{c1::Bradycardia}}{{c1::Extravasation necrosis}}
Published	02/20/2025	Dopamine MOA: {{c1::α and β agonist}}
Published	02/20/2025	Carvedilol therapeutics: {{c1::Systolic}} heart failure {{c1::Hypertension}} {{c1::Angina}} {{c1::Cirrhosis}}
Published	02/20/2025	Dopamine therapeutics:{{c1::Septic shock}}
Published	02/20/2025	Carvedilol adverse effects: {{c1::Bradycardia}} {{c1::AV}} block {{c1::Fatigue}} {{c1::Bronchoconstriction}}
Published	02/20/2025	Dopamine adverse effects:{{c1::Tachycardia}}{{c1::Vasoconstriction}}Local {{c1::necrosis}}
Published	02/22/2025	The heart has {{c1::β1}} adrenergic and {{c1::M2}} muscarinic receptors
Published	02/20/2025	At the heart: M2: {{c1::decelerates}} HR β1: {{c1::accelerates}} HR and contractility
Published	02/22/2025	Vasculature has {{c1::α1}} & {{c1::β2}} adrenergic and {{c1::M3}} muscarinic receptors
Published	02/24/2025	Within vasculature: M3: Nitric oxide {{c1::vasodilation}} α1: {{c1::vasoconstriction}}β2: {{c1::vasodilation}} of {{c1::skeletal muscles}} &…
Published	02/20/2025	At the lungs: M3: {{c1::bronchoconstriction}} & increased {{c1::mucus}} secretion β2: {{c1::bronchodilation}}
Published	02/22/2025	The lungs have {{c1::β2}} adrenergic and {{c1::M3}} muscarinic receptors
Status	Last Update	Fields